Multicenter Investigation of Gepotidacin (GSK2140944) Agar Dilution Quality Control Determinations for Neisseria gonorrhoeae ATCC 49226

Gepotidacin, a novel triazaacenaphthylene antibacterial agent, is the first in a new class of type IIA topoisomerase inhibitors with activity against many biothreat and conventional pathogens, including Neisseria gonorrhoeae. To assist ongoing clinical studies of gepotidacin to treat gonorrhea, a mu...

Full description

Saved in:
Bibliographic Details
Published in:Antimicrob Agents Chemother
Main Authors: Jones, Ronald N., Fedler, Kelley A., Scangarella-Oman, Nicole E., Ross, James E., Flamm, Robert K.
Format: Artigo
Language:Inglês
Published: American Society for Microbiology 2016
Subjects:
Susceptibility
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4914643/
https://ncbi.nlm.nih.gov/pubmed/27161642
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00527-16
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items